SCHEMBL4810409

SCHEMBL4810409

O=[N+]([O-])c1ccccc1Nc1ccccn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.71
KMT2A Q03164 7/20 0.71
NPC1 O15118 3/20 0.67
MAPT P10636 7/20 0.61
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 4/20 0.61
RAB9A P51151 3/20 0.61
LMNA P02545 2/20 0.61
MITF O75030 1/20 0.61
MAPK10 P53779 1/20 0.61
GFER P55789 1/20 0.61
GAA P10253 2/20 0.57
MAPK1 P28482 4/20 0.57
TDP1 Q9NUW8 2/20 0.57
CASP7 P55210 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
PKM P14618 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HTT P42858 1/20 0.50
NOD2 Q9HC29 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29744982 1.00 MEN1 (0.71) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL16038460 0.84 ALDH1A1 (0.67) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL7778637 0.84 ALDH1A1 (0.54) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL6951149 0.83 MAPK1 (0.61) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL19062115 0.82 MEN1 (0.61) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL4929418 0.82 MEN1 (0.61) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL11900688 0.82 MEN1 (0.61) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL6832746 0.82 MEN1 (0.61) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL31220843 0.82 MEN1 (0.73) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL31220848 0.82 MEN1 (0.73) MEN1KMT2ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329288-B2 N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof L'OREAL S.A. (FR) 2008-02-12 US claimed
US-20060005323-A1 N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof L'OREAL S.A. (FR) 2006-01-12 US claimed
CN-118993822-A Method for green synthesis of aryl nitrifier by using cheap cobalt salt as catalyst 广东石油化工学院 2024-11-22 CN disclosed
CN-117088808-A Antifungal compound and application thereof 中国人民解放军海军军医大学 2023-11-21 CN disclosed
US-20080207659-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE 4 RANBAXY LABORATORIES LIMITED (IN) 2008-08-28 US disclosed
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed
US-7329288-B2 N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof L'OREAL S.A. (FR) 2008-02-12 US disclosed
US-20060005323-A1 N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof L'OREAL S.A. (FR) 2006-01-12 US disclosed
EP-1568694-A1 N-heteroaryl-para-phenylene diamines for colouring hair L'OREAL (FR) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207659-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE 4 PDE4A, PDE4B, PDE4C MEN1 4784/4885KMT2A 4487/4885NPC1 4154/4885
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE SLC6A4, SLC6A2, SLC6A3 MEN1 4156/4885KMT2A 1555/4885NPC1 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.